تحميل...
Recent translational research: antiangiogenic therapy for breast cancer – where do we stand?
The central importance of angiogenesis and our understanding of how new blood vessels are formed have led to the development of novel antiangiogenic therapies. Although the number of agents in development has grown exponentially, only one phase III trial in breast cancer has been completed. In that...
محفوظ في:
| الحاوية / القاعدة: | Breast Cancer Res |
|---|---|
| المؤلف الرئيسي: | |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
BMC
2004
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400679/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15084233/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/bcr782 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|